A brief measure for assessing the severity of generalized anxiety symptoms over the past two weeks.
Publisher: Developed by Drs. Spitzer, Kroenke, Williams, and Löwe with an unrestricted educational grant from Pfizer Inc.
Citation: Spitzer, R.L., Kroenke, K., Williams, J.B.W., & Löwe, B. (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine, 166(10), 1092-1097.